Kovitz Investment Group Partners
ABBV icon

Kovitz Investment Group Partners’s AbbVie ABBV Stock Holding History

Kovitz Investment Group Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Sell
7,181
-1,175
-14% -$261K 0.04% 260
2025
Q4 		$1.91M Sell
8,356
-187,938
-96% -$42.8M 0.04% 239
2025
Q3 		$45.5M Buy
196,294
+15,082
+8% +$3.07M 0.18% 117
2025
Q2 		$33.6M Buy
181,212
+87,994
+94% +$16.4M 0.14% 131
2025
Q1 		$19.5M Buy
93,218
+20,032
+27% +$3.89M 0.1% 174
2024
Q4 		$13M Buy
73,186
+4,828
+7% +$888K 0.06% 222
2024
Q3 		$6.72M Buy
68,358
+45,336
+197% +$8.46M 0.05% 294
2024
Q2 		$3.95M Buy
23,022
+8,190
+55% +$1.36M 0.03% 322
2024
Q1 		$2.7M Buy
14,832
+7,633
+106% +$1.32M 0.03% 270
2023
Q4 		$1.12M Sell
7,199
-228
-3% -$33.2K 0.02% 280
2023
Q3 		$1.11M Sell
7,427
-11
-0.1% -$1.61K 0.02% 270
2023
Q2 		$1M Sell
7,438
-6,174
-45% -$905K 0.01% 296
2023
Q1 		$2.17M Sell
13,612
-5,010
-27% -$766K 0.04% 237
2022
Q4 		$3.01M Sell
18,622
-439
-2% -$67.3K 0.06% 205
2022
Q3 		$2.56M Sell
19,061
-1,816
-9% -$261K 0.06% 205
2022
Q2 		$3.2M Sell
20,877
-13,360
-39% -$2.04M 0.07% 201
2022
Q1 		$5.55M Sell
34,237
-30,337
-47% -$4.41M 0.11% 143
2021
Q4 		$6.92M Buy
64,574
+10,699
+20% +$1.26M 0.16% 92
2021
Q3 		$5.81M Sell
53,875
-20,904
-28% -$2.39M 0.12% 129
2021
Q2 		$8.42M Buy
74,779
+14,950
+25% +$1.68M 0.17% 94
2021
Q1 		$6.47M Sell
59,829
-4,594
-7% -$491K 0.15% 105
2020
Q4 		$6.9M Sell
64,423
-9,604
-13% -$923K 0.17% 90
2020
Q3 		$6.48M Buy
74,027
+2,811
+4% +$265K 0.18% 87
2020
Q2 		$6.99M Buy
71,216
+32,920
+86% +$2.9M 0.22% 77
2020
Q1 		$2.92M Buy
38,296
+5,729
+18% +$488K 0.11% 134
2019
Q4 		$2.88M Buy
32,567
+6,279
+24% +$521K 0.08% 163
2019
Q3 		$1.99M Buy
26,288
+14,711
+127% +$1.01M 0.06% 198
2019
Q2 		$842K Sell
11,577
-1,568
-12% -$123K 0.03% 280
2019
Q1 		$1.06M Buy
13,145
+573
+5% +$46.9K 0.03% 270
2018
Q4 		$1.16M Sell
12,572
-550
-4% -$48.4K 0.05% 180
2018
Q3 		$1.24M Buy
13,122
+602
+5% +$57.1K 0.06% 83
2018
Q2 		$1.16M Sell
12,520
-540
-4% -$52.7K 0.05% 85
2018
Q1 		$1.24M Sell
13,060
-11,292
-46% -$1.24M 0.06% 81
2017
Q4 		$2.35K Sell
24,352
-425
-2% -$40.1K 0.1% 59
2017
Q3 		$2.2M Sell
24,777
-1,100
-4% -$83.7K 0.11% 60
2017
Q2 		$1.88M Sell
25,877
-4,858
-16% -$327K 0.1% 61
2017
Q1 		$2M Sell
30,735
-177
-0.6% -$11.1K 0.11% 66
2016
Q4 		$1.94M Sell
30,912
-100
-0.3% -$6.1K 0.11% 60
2016
Q3 		$1.96M Buy
31,012
+33
+0.1% +$2.14K 0.12% 68
2016
Q2 		$1.92M Sell
30,979
-3,515
-10% -$214K 0.13% 67
2016
Q1 		$1.97M Buy
+34,494
New +$1.92M 0.12% 68

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kovitz Investment Group Partners's ABBV Position: Q1 2026 in Review

Kovitz Investment Group Partners reduced its AbbVie (ABBV) stake by 14% in Q1 2026, selling an estimated $261K and leaving 7,181 shares worth $1.56M. The position accounts for 0.04% of the portfolio, ranked #260.

Kovitz Investment Group Partners first reported a position in ABBV in Q1 2016 and has held it in 41 quarters since. The position peaked at $45.5M in Q3 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Kovitz Investment Group Partners held 7,181 shares of AbbVie worth $1.56M as of Q1 2026.
  • Kovitz Investment Group Partners sold 1,175 AbbVie shares in Q1 2026, an estimated $261K.
  • AbbVie made up 0.04% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #260 holding.
  • Kovitz Investment Group Partners first reported a position in AbbVie in Q1 2016 and has held it in 41 quarters since.
  • Kovitz Investment Group Partners's AbbVie position peaked at $45.5M in Q3 2025.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.